Location of Repository

Early mortality and loss to follow-up in HIV-infected children starting antiretroviral therapy in Southern Africa.

By Lukas Fenner, Martin W G Brinkhof, Olivia Keiser, Ralf Weigel, Morna Cornell, Harry Moultrie, Hans Prozesky, Karl Technau, Brian Eley, Paula Vaz, Margaret Pascoe, Janet Giddy, Gilles Van Cutsem, Robin Wood, Matthias Egger and Mary-Ann Davies

Abstract

BACKGROUND: Many HIV-infected children in Southern Africa have been started on antiretroviral therapy (ART), but loss to follow up (LTFU) can be substantial. We analyzed mortality in children retained in care and in all children starting ART, taking LTFU into account. PATIENTS AND METHODS: Children who started ART before the age of 16 years in 10 ART programs in South Africa, Malawi, Mozambique, and Zimbabwe were included. Risk factors for death in the first year of ART were identified in Weibull models. A meta-analytic approach was used to estimate cumulative mortality at 1 year. RESULTS: Eight thousand two hundred twenty-five children (median age 49 months, median CD4 cell percent 11.6%) were included; 391 (4.8%) died and 523 (7.0%) were LTFU in the first year. Mortality at 1 year was 4.5% [95% confidence interval (CI): 2.8% to 7.4%] in children remaining in care, but 8.7% (5.4% to 12.1%) at the program level, after taking mortality in children and LTFU into account. Factors associated with mortality in children remaining in care included age [adjusted hazard ratio (HR) 0.37; 95% CI: 0.25 to 0.54 comparing > or =120 months with <18 months], CD4 cell percent (HR: 0.56; 95% CI: 0.39 to 0.78 comparing > or =20% with <10%), and clinical stage (HR: 0.12; 95% CI: 0.03 to 0.45 comparing World Health Organization stage I with III/IV). CONCLUSIONS: In children starting ART and remaining in care in Southern Africa mortality at 1 year is <5% but almost twice as high at the program level, when taking LTFU into account. Age, CD4 percentage, and clinical stage are important predictors of mortality at the individual level

Year: 2010
DOI identifier: 10.1097/QAI.0b013e3181e0c4cf
OAI identifier: oai:fieldresearch.msf.org:10144/112734
Provided by: MSF Field Research
Journal:

Suggested articles

Preview

Citations

  1. Addressing an idiosyncrasy in estimating survival curves using double sampling in the presence of self-selected right censoring.
  2. Adherence to antiretroviral therapy in young children in Cape Town, South Africa, measured by medication return and caregiver self-report: a prospective cohort study.
  3. (2007). Antiretroviral therapy for children: challenges and opportunities. Ann Trop Paediatr.
  4. (2007). Antiretroviral therapy for HIV-1-infected children in Haiti. J Infect Dis.
  5. (2008). Association of antiretroviral and clinic adherence with orphan status among HIV-infected children in Western Kenya. J Acquir Immune Defic Syndr.
  6. (2008). Available at: http://www.who.int/hiv/pub/towards_universal_access_ report_2008.pdf.
  7. Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia.
  8. (2007). Cohort profile: the North American
  9. Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Study Group. Response to combination antiretroviral therapy: variation by age.
  10. (2009). Correcting mortality for loss to follow up: a graphical approach applied to ART programmes in resource-limited settings.
  11. (2009). Cost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Cote d’Ivoire appraisal. PLoS Med.
  12. (2008). Differences in factors associated with initial growth, CD4, and viral load responses to ART in HIV-infected children in Kampala, Uganda, and the United Kingdom/Ireland. J Acquir Immune Defic Syndr.
  13. (2008). Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Bull World Health Organ.
  14. (2008). Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa. Lancet Infect Dis.
  15. (2008). Low risk of death, but substantial program attrition, in pediatric HIV treatment cohorts in Sub-Saharan Africa. J Acquir Immune Defic Syndr.
  16. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between lowincome and high-income countries.
  17. (2009). Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortality. PLoS Med.
  18. (2009). Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS One.
  19. Multiple imputation of missing values: an update.
  20. (2008). Organization. Antiretroviral therapy of HIV infection in infants and children: towards universal access. Available at: www.who.int/ hiv/pub/guidelines/WHOpaediatric.pdf. Accessed
  21. (2008). Organization. Data collector. Available at: https://extranet. who.int/datacol/WebHelp/DataCollector_OLH.htm. Accessed
  22. Organization. Towards Universal Access. Scaling Up Priority HIV/AIDS Interventions in the Health Sector.
  23. (2008). Organization. WHO child growth standards. Available at: http://www.who.int/childgrowth/standards/en/. Accessed
  24. (2009). Outcomes of patient active tracing by lay community workers in a decentralized HIV care program of rural
  25. Outcomes of the South African National Antiretroviral Treatment Programme for children: the IeDEA Southern Africa collaboration.
  26. Paediatric antiretroviral treatment programmes in sub-Saharan Africa: a review of published clinical studies.
  27. (2007). Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med.
  28. Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZuluNatal, South Africa.
  29. (2008). Public-health and individual approaches to antiretroviral therapy: township South Africa and Switzerland compared. PLoS Med.
  30. Regression analysis of grouped survival data: informative censoring and double sampling.
  31. Sampling-based approach to determining outcomes of patients lost to follow-up in antiretroviral therapy scale-up programs in Africa.
  32. (2010). Sampling-based approaches to improve estimation of mortality among patient dropouts: experience from a large PEPFAR-funded program in Western Kenya. PLoS One. 2008;3:e3843. APPENDIX I: IEDEA-SA PARTICIPATING SITES Margaret Pascoe, Newlands Clinic,
  33. (2008). World Health Organization.Growth reference data for 5–19 years. Available at: http://www.who.int/growthref/en/. Accessed
  34. (2007). World Health Organization.Towards universal access by 2010: How WHO is working with countries to scale-up HIV prevention, treatment, care and support. Available at: http://www.who.int/hiv/mediacenter/universal_ access_progres_report_en.pdf.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.